Markey's Post-Outbreak Bill May Fall Short Of Desired Overhaul

Law360, New York (November 2, 2012, 8:59 PM EDT) -- Rep. Edward Markey, D-Mass., introduced legislation this week that aims to strengthen the U.S. Food and Drug Administration's oversight of compounding pharmacies, but attorneys say the bill grants the agency authority it already has and maintains the same federal-state regulatory split that critics have linked to the recent meningitis outbreak.

The bill, known as the Verifying Authority and Legality in Drug Compounding Act, would preserve state pharmacy boards' oversight of compounders that manufacture drugs that are not commercially available, based on prescriptions for individual patients. If a compounder manufactures drugs outside of that context — by making them in bulk, for...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!